PROZONER
PROZONER
Each stock's 10,000-path forecast, rendered as light.
PROZONER (PROZONER) Stock Analysis & Case Study
Is PROZONER a good buy? The data-driven verdict.
PROZONER (PROZONER) trades at ₹43,on the numbers it high-risk on the numbers, a Downstox Snapshot Score of 20/100.
On the numbers, PROZONER (PROZONER) high-risk on the numbers, a Downstox Snapshot Score of 20/100, weighing expensive at 61.0× earnings, ROE of 2.3%, a 49% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
PROZONER fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How PROZONER ranks against the 2,373 companies in our screener
- PROZONER's market cap of 652 Cr ranks in the 31st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PROZONER's book value of ₹30 ranks in the 23rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PROZONER's promoter holding of 53.6% ranks in the 38th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PROZONER's 3-year profit (PAT) growth of -24.0% ranks in the 9th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PROZONER's 3-year revenue growth of 4.0% ranks in the 32nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PROZONER's debt-to-equity ratio of 1.44x is lower than 8% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is PROZONER overvalued? PROZONER P/E vs peers
PROZONER trades at 61.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
PROZONER share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of PROZONER history (5%/yr drift, 48%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| PROZONER 2027 | ₹23 | ₹42 | ₹79 | -1% |
| PROZONER 2028 | ₹17 | ₹42 | ₹103 | -1% |
| PROZONER 2029 | ₹14 | ₹42 | ₹123 | -2% |
| PROZONER 2030 | ₹12 | ₹42 | ₹144 | -2% |
| PROZONER 2031 | ₹10 | ₹42 | ₹168 | -3% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability PROZONER goes up, or doubles?
The bull case for PROZONER
- Low price-to-book of 1.43×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹123.
The bear case & risks
- PROZONER's P/E of 61.0x is lower than 20% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PROZONER's return on equity of 2.3% ranks in the 21st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PROZONER's Piotroski F-Score of 3/8 ranks in the 15th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- High historical volatility (48%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹14.
PROZONER volatility & expected range, how bumpy is the ride?
Over the last 9.8 years PROZONER compounded at 5%/year with annualized volatility of 48%. That volatility implies a 1-year 80% range of ₹23-₹79, the honest backbone behind any single price target.
PROZONER price forecast, the full 60-month probability fan
PROZONER price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds PROZONER hits common targets within the simulated horizon?
Full multi-horizon detail on the PROZONER price target & forecast page.
PROZONER Piotroski F-Score: 3/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. PROZONER scores 3/8, weak on the financial-strength checks.
PROZONER MTF margin & leverage across 1 brokers
Margin Trading Facility lets you buy PROZONER with part of the capital. Lower margin % = higher leverage. Rates compared across 1 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Share IndiaCHEAPEST | 38.32% | 2.6× |
Compare every broker on the PROZONER MTF page.
About PROZONER: sector, index & market-cap context
PROZONER (PROZONER) is a small-cap NSE-listed company, with a market capitalisation of ₹652 Cr. See more stocks on our screener.
How the PROZONER Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of PROZONER's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
PROZONER analysis, FAQs
Is PROZONER (PROZONER) a good buy?
On the numbers, PROZONER (PROZONER) high-risk on the numbers, a Downstox Snapshot Score of 20/100, weighing expensive at 61.0× earnings, ROE of 2.3%, a 49% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is PROZONER overvalued or undervalued?
PROZONER trades at 61.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the PROZONER share price target for 2031?
PROZONER's probability-weighted 2031 median target is ₹42, with an 80% range of ₹10-₹168 (10,000-path Monte-Carlo).
What is the probability PROZONER doubles in 5 years?
The modelled probability of PROZONER reaching ₹85 (2×) within 5 years is 25%.
What is the bull case for PROZONER?
Low price-to-book of 1.43×, the market is paying little over the company's net assets.
What are the risks in PROZONER?
PROZONER's P/E of 61.0x is lower than 20% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. PROZONER's return on equity of 2.3% ranks in the 21st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. PROZONER's Piotroski F-Score of 3/8 ranks in the 15th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.